抑制USP7促进老年骨质疏松小鼠早期骨整合
本研究在衰老骨髓来源巨噬细胞(BMDMs)和老年骨髓间充质干细胞(BMSCs)中观察USP7缺失及抑制剂P5091的作用,并在老年骨质疏松小鼠中评估骨整合。USP7缺失和P5091抑制衰老BMDMs炎症并促进老年BMSCs成骨分化;在老年骨质疏松小鼠中骨整合期较年轻小鼠延长,P5091促进早期骨整合,可能与种植体周围巨噬细胞胞葬作用有关。
要点
- USP7缺失和P5091抑制衰老BMDMs炎症并促进老年BMSCs成骨分化。
- 老年骨质疏松小鼠骨整合期较年轻小鼠延长,P5091促进早期骨整合。
- USP7缺失经EPSIN1/LRP1通路增强衰老BMDMs胞葬作用并选择性诱导老年BMSCs凋亡。
核心结论
- 本研究提示抑制USP7可能通过促进巨噬细胞胞葬作用和老年BMSCs凋亡加速老年骨质疏松条件下的骨整合过程。
研究设计与样本
- 研究在衰老骨髓来源巨噬细胞(BMDMs)和老年骨髓间充质干细胞(BMSCs)中进行细胞实验,并在老年骨质疏松小鼠中评估骨整合。
主要发现
- USP7缺失和P5091抑制衰老BMDMs炎症并促进老年BMSCs成骨分化。
- mRNA-Seq显示USP7缺失经EPSIN1/低密度脂蛋白受体相关蛋白1(LRP1)通路增强衰老BMDMs胞葬作用并选择性诱导老年BMSCs凋亡。
- 老年骨质疏松小鼠骨整合期较年轻小鼠延长,P5091促进早期骨整合,可能与种植体周围巨噬细胞胞葬作用有关。
临床怎么用
- 作者认为该发现有助于理解骨质疏松条件下种植体周围骨微环境的细胞相互作用和信号机制,并可能为开发增强骨整合质量、缩短老年骨质疏松患者缺牙期的新疗法提供临床意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although elderly osteoporotic patients have similar implant survival rates compared with those of normal individuals, they require longer healing periods to achieve proper osseointegration. This may be related to chronic inflammatory responses and impaired stem cell repair functions in the osteoporotic bone microenvironment. Recently, the deubiquitinating enzyme, ubiquitin-specific peptidase 7 (USP7), was found to regulate the macrophage immune response and modulate stem cell osteogenic differentiation. The selective inhibitor of USP7, P5091, has also been found to promote bone repair and homeostasis in osteoporotic conditions. However, the roles of USP7 and P5091 in osteoimmunology and dental implant osseointegration under senile osteoporotic conditions remain unclear. In this study, USP7 depletion and P5091 were shown to inhibit inflammation in senescent bone marrow-derived macrophages (BMDMs) and promote osteogenic differentiation in aged bone marrow mesenchymal stromal cells (BMSCs). Furthermore, mRNA-Seq revealed that USP7 depletion could enhance efferocytosis in senescent BMDMs through the EPSIN1/low-density lipoprotein receptor-related protein 1 (LRP1) pathway and selectively induce apoptosis (senolysis) in aged BMSCs. In senile osteoporotic mice, we found that the osseointegration period was prolonged compared with young mice, and P5091 promoted the early stage of osseointegration, which may be related to macrophage efferocytosis around the implant. Collectively, this study suggests that USP7 inhibition may accelerate the osseointegration process in senile osteoporotic conditions by promoting macrophage efferocytosis and aged BMSCs apoptosis. This has implications for understanding the cellular interactions and signaling mechanisms in the peri-implant bone microenvironment under osteoporotic conditions. It may also provide clinical significance in developing new therapies to enhance osseointegration quality and shorten the edentulous period in elderly osteoporotic patients.
引用
- Zhou F, Wang Z, Li H, et al. USP7 Inhibition Promotes Early Osseointegration in Senile Osteoporotic Mice. J Dent Res. 2024. PMID: 39651622. doi:10.1177/00220345241288570
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。